{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:41:47Z","timestamp":1787586107190,"version":"build-2736575974"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease around the world, and it often coexists with insulin resistance-related diseases including obesity, diabetes, hyperlipidemia, and hypertension, which seriously threatens human health. Better prevention and treatment strategies are required to improve the impact of NAFLD. Although needle biopsy is an effective tool for diagnosing NAFLD, this method is invasive and difficult to perform. Therefore, it is very important to develop more efficient approaches for the early diagnosis of NAFLD. Traditional Chinese medicine (TCM) can play a certain role in improving symptoms and protecting target organs, and its mechanism of action needs to be further studied. Metabolomics, the study of all metabolites that is thought to be most closely associated with the patients\u2019 characters, can provide useful clinically biomarkers that can be applied to NAFLD and may open up new methods for diagnosis. Metabolomics technology is consistent with the overall concept of TCM, and it can also be used as a potential mechanism to explain the effects of TCM by measuring biomarkers by metabolomics. Based on PubMed\/MEDLINE and other databases, this paper retrieved relevant literature NAFLD and TCM intervention in NAFLD using metabolomics technology in the past 5\u00a0years were searched, and the specific metabolites associated with the development of NAFLD and the potential mechanism of Chinese medicine on improving symptoms were summarized.<\/jats:p>","DOI":"10.3389\/fphar.2022.971561","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T10:51:10Z","timestamp":1661424670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine"],"prefix":"10.3389","volume":"13","author":[{"given":"Mingmei","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases","volume":"32","author":"Abenavoli","year":"2018","journal-title":"Phytother. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mito.2020.12.010","article-title":"Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Ajaz","year":"2021","journal-title":"Mitochondrion"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2001178","DOI":"10.1002\/mnfr.202001178","article-title":"Effect of mastiha supplementation on NAFLD: The MAST4HEALTH randomised, controlled trial","volume":"65","author":"Amerikanou","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1038\/s41598-022-10481-9","article-title":"Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool","volume":"12","author":"Babu","year":"2022","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1021\/pr1002593","article-title":"Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease","volume":"9","author":"Barr","year":"2010","journal-title":"J. Proteome Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","article-title":"Metabolomics enables precision medicine: \"A white paper, community perspective","volume":"12","author":"Beger","year":"2016","journal-title":"Metabolomics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00394-022-02846-7","article-title":"Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients","volume":"61","author":"Bischoff","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.phrs.2019.04.016","article-title":"Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH","volume":"144","author":"Boeckmans","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MOG.0000000000000349","article-title":"Intestinal microbiota and nonalcoholic steatohepatitis","volume":"33","author":"Brandl","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"Nafld: A multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13020-018-0221-x","article-title":"Systems biology approaches in the study of Chinese herbal formulae","volume":"13","author":"Cai","year":"2018","journal-title":"Chin. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1136\/gutjnl-2018-317584","article-title":"Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease","volume":"68","author":"Caussy","year":"","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD","volume":"49","author":"Caussy","year":"","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cld.2015.10.004","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"20","author":"Chacko","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/apt.14674","article-title":"Randomised clinical trial: A leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease","volume":"47","author":"Chalasani","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.26355\/eurrev_202007_21912","article-title":"A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease","volume":"24","author":"Chang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"606759","DOI":"10.3389\/fphar.2020.606759","article-title":"Gallic acid ameliorated impaired lipid homeostasis in a mouse model of high-fat diet-and streptozotocin-induced NAFLD and diabetes through improvement of -oxidation and ketogenesis","volume":"11","author":"Chao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1142\/S0192415X18500891","article-title":"Management of diabetes mellitus with puerarin, a natural isoflavone from Pueraria lobata","volume":"46","author":"Chen","year":"2018","journal-title":"Am. J. Chin. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","article-title":"Berberine and its role in chronic disease","volume":"928","author":"Cicero","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fphar.2020.00858","article-title":"Untargeted metabolomic analysis of the effects and mechanism of nuciferine treatment on rats with nonalcoholic fatty liver disease","volume":"11","author":"Cui","year":"","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"584090","DOI":"10.3389\/fphar.2020.584090","article-title":"Da-chai-hu decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease through remodeling the gut microbiota and modulating the serum metabolism","volume":"11","author":"Cui","year":"","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese medicine in nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/liv.14743","article-title":"Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids","volume":"41","author":"de Mello","year":"2021","journal-title":"Liver Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E3943","DOI":"10.3390\/molecules24213943","article-title":"Lipidomic analysis of the protective effects of shenling baizhu san on non-alcoholic fatty liver disease in rats","volume":"24","author":"Deng","year":"2019","journal-title":"Mol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1039\/d1fo03921k","article-title":"Changes in the serum metabolomic profiles of subjects with NAFLD in response to n-3 PUFAs and phytosterol ester: A double-blind randomized controlled trial","volume":"13","author":"Ding","year":"2022","journal-title":"Food Funct."},{"key":"B31","doi-asserted-by":"publisher","first-page":"118868","DOI":"10.1016\/j.lfs.2020.118868","article-title":"Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-\u03b1 signaling in obese mice","volume":"266","author":"Diniz","year":"2021","journal-title":"Life Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3748\/wjg.v23.i15.2771","article-title":"Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease","volume":"23","author":"Dong","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.3390\/molecules22020191","article-title":"Silymarin\/silybin and chronic liver disease: A marriage of many years","volume":"22","author":"Federico","year":"2017","journal-title":"Mol. (Basel, Switz."},{"key":"B34","doi-asserted-by":"publisher","first-page":"727636","DOI":"10.3389\/fphar.2021.727636","article-title":"Study on the hepatoprotection of Schisandra chinensis caulis polysaccharides in nonalcoholic fatty liver disease in rats based on metabolomics","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12944-021-01526-5","article-title":"Serum lipids are associated with nonalcoholic fatty liver disease: A pilot case-control study in Mexico","volume":"20","author":"Flores","year":"2021","journal-title":"Lipids Health Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.21037\/apm-21-2455","article-title":"Effect of amlodipine on ventricular hypertrophy in hypertension patients: A systematic review and meta-analysis","volume":"10","author":"Gao","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"E642","DOI":"10.3390\/nu9070642","article-title":"A branched-chain amino acid-related metabolic signature characterizes obese adolescents with non-alcoholic fatty liver disease","volume":"9","author":"Goffredo","year":"2017","journal-title":"Nutrients"},{"key":"B38","doi-asserted-by":"publisher","first-page":"113964","DOI":"10.1016\/j.jpba.2021.113964","article-title":"Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing","volume":"197","author":"Gong","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B39","doi-asserted-by":"publisher","first-page":"107173","DOI":"10.1016\/j.intimp.2020.107173","article-title":"Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses","volume":"91","author":"Gong","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fphar.2020.00833","article-title":"Integrated metagenomic and metabolomic analyses of the effect of Astragalus polysaccharides on alleviating high-fat diet-induced metabolic disorders","volume":"11","author":"Hong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.biopha.2018.01.072","article-title":"Antidotal or protective effects of curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review","volume":"99","author":"Hosseini","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12967-021-02820-7","article-title":"Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry","volume":"19","author":"Hu","year":"2021","journal-title":"J. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jch.13543","article-title":"A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension","volume":"21","author":"Huang","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1142\/S0192415X21500749","article-title":"Schisandra sphenanthera: A comprehensive review of its botany, phytochemistry, pharmacology, and clinical applications","volume":"49","author":"Huang","year":"2021","journal-title":"Am. J. Chin. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ptr.6252","article-title":"Berberine and barberry (berberis vulgaris): A clinical review","volume":"33","author":"Imenshahidi","year":"2019","journal-title":"Phytother. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"E168","DOI":"10.3390\/metabo10040168","article-title":"Distinguishing NASH histological severity using a multiplatform metabolomics approach","volume":"10","author":"Ioannou","year":"2020","journal-title":"Metabolites"},{"key":"B47","doi-asserted-by":"publisher","first-page":"31520","DOI":"10.1038\/srep31520","article-title":"Identification of salivary metabolomic biomarkers for oral cancer screening","volume":"6","author":"Ishikawa","year":"2016","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mas.21548","article-title":"Metabolomics toward personalized medicine","volume":"38","author":"Jacob","year":"2019","journal-title":"Mass Spectrom. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist's point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"841132","DOI":"10.3389\/fphar.2022.841132","article-title":"Rifaximin ameliorates non-alcoholic steatohepatitis in mice through regulating gut microbiome-related bile acids","volume":"13","author":"Jian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpeds.2016.01.026","article-title":"Amino acid metabolism is altered in adolescents with nonalcoholic fatty liver disease-an untargeted, high resolution metabolomics study","volume":"172","author":"Jin","year":"2016","journal-title":"J. Pediatr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: Beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ejcn.2017.43","article-title":"Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample","volume":"71","author":"Koch","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"713234","DOI":"10.3389\/fmicb.2021.713234","article-title":"Metabolomic predictors of non-alcoholic steatohepatitis and advanced fibrosis in children","volume":"12","author":"Kordy","year":"2021","journal-title":"Front. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jnutbio.2019.03.006","article-title":"Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","volume":"68","author":"Lee","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"154015","DOI":"10.1016\/j.metabol.2019.154015","article-title":"Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity","volume":"103","author":"Lee","year":"2020","journal-title":"Metabolism."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: A nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"103661","DOI":"10.1016\/j.ebiom.2021.103661","article-title":"The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma","volume":"73","author":"Lewinska","year":"2021","journal-title":"EBioMedicine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1212\/WNL.0000000000003663","article-title":"Metabolomic biomarkers as strong correlates of Parkinson disease progression","volume":"88","author":"LeWitt","year":"2017","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/d0fo02736g","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"B61","doi-asserted-by":"publisher","first-page":"112896","DOI":"10.1016\/j.jep.2020.112896","article-title":"Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice","volume":"258","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B62","first-page":"467","article-title":"Urinary metabolomic study on liver depression and spleen deficiency syndrome of nonalcoholic fatty liver in rats","volume":"25","author":"Li","year":"2019","journal-title":"J. Basic Chin. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/bph.15768","article-title":"Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota","volume":"179","author":"Li","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/17425255.2019.1650913","article-title":"S-amlodipine-bisoprolol combination therapy caused elevated transaminases and triglyceride levels in healthy Chinese subjects: A randomized controlled, open-label, multiple-dose pharmacokinetic interaction study","volume":"15","author":"Liu","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"114058","DOI":"10.1016\/j.jpba.2021.114058","article-title":"Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease","volume":"200","author":"Liu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B66","doi-asserted-by":"publisher","first-page":"118457","DOI":"10.1016\/j.lfs.2020.118457","article-title":"Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db\/db mice","volume":"261","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.molmet.2021.101367","article-title":"Serum integrative omics reveals the landscape of human diabetic kidney disease","volume":"54","author":"Liu","year":"2021","journal-title":"Mol. Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"112219","DOI":"10.1016\/j.jep.2019.112219","article-title":"Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique","volume":"246","author":"Liu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B69","first-page":"1246","article-title":"Serum metabolomics study on nonalcoholic fatty liver disease with liver damage of different syndromes","volume":"32","author":"Ma","year":"2017","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"5856201","DOI":"10.1155\/2018\/5856201","article-title":"Changes of the fatty acid profile in erythrocyte membranes of patients following 6-month dietary intervention aimed at the regression of nonalcoholic fatty liver disease (NAFLD)","volume":"2018","author":"Maciejewska","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s12328-021-01491-7","article-title":"Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: A systematic review and meta-analysis","volume":"14","author":"Malik","year":"2021","journal-title":"Clin. J. Gastroenterol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"683250","DOI":"10.3389\/fmed.2021.683250","article-title":"Adiponectin, leptin, and IGF-1 are useful diagnostic and stratification biomarkers of NAFLD","volume":"8","author":"Marques","year":"2021","journal-title":"Front. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.32427","article-title":"Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles","author":"Mart\u00ednez-Arranz","year":"2022","journal-title":"Hepatology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","article-title":"Untargeted metabolomics as a diagnostic tool in NAFLD: Discrimination of steatosis, steatohepatitis and cirrhosis","volume":"17","author":"Masarone","year":"2021","journal-title":"Metabolomics."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/nu14091813","article-title":"Effect of a six-month lifestyle intervention on the physical activity and fitness status of adults with NAFLD and metabolic syndrome","volume":"14","author":"Mascar\u00f3","year":"2022","journal-title":"Nutrients"},{"key":"B76","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: Biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11306-021-01810-6","article-title":"Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: Effect of PNPLA3 genotype","volume":"17","author":"Mazzini","year":"2021","journal-title":"Metabolomics."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jhep.2018.07.013","article-title":"An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers","volume":"69","author":"Mazzotti","year":"2018","journal-title":"J. Hepatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/apt.15710","article-title":"Accurate non-invasive diagnosis and staging of non-alcoholic fatty liver disease using the urinary steroid metabolome","volume":"51","author":"Moolla","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","article-title":"Liraglutide modulates gut microbiota and reduces NAFLD in obese mice","volume":"62","author":"Moreira","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1039\/d0mo00176g","article-title":"Metabolomics: Small molecules that matter more","volume":"17","author":"Muthubharathi","year":"2021","journal-title":"Mol. Omics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism."},{"key":"B83","doi-asserted-by":"publisher","first-page":"112999","DOI":"10.1016\/j.jep.2020.112999","article-title":"An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity","volume":"260","author":"Park","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jprot.2019.04.008","article-title":"Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker","volume":"200","author":"Pe\u00f1a-Bautista","year":"2019","journal-title":"J. Proteomics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/liv.14888","article-title":"Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis","volume":"41","author":"Perakakis","year":"2021","journal-title":"Liver Int."},{"key":"B86","doi-asserted-by":"publisher","first-page":"127676","DOI":"10.1016\/j.foodchem.2020.127676","article-title":"Chicory (cichorium intybus L.) as a food ingredient - nutritional composition, bioactivity, safety, and health claims: A review","volume":"336","author":"Perovi\u0107","year":"2021","journal-title":"Food Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet (London, Engl."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s10787-020-00692-9","article-title":"Appraisal of disease-modifying potential of amlodipine as an anti-arthritic agent: New indication for an old drug","volume":"28","author":"Qasim","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2017.08.022","article-title":"Metabonomics screening of serum identifies pyroglutamate as a diagnostic biomarker for nonalcoholic steatohepatitis","volume":"473","author":"Qi","year":"2017","journal-title":"Clin. Chim. Acta."},{"key":"B90","doi-asserted-by":"publisher","first-page":"153140","DOI":"10.1016\/j.phymed.2019.153140","article-title":"Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2\/HO-1 antioxidant signaling pathway","volume":"67","author":"Qiu","year":"2020","journal-title":"Phytomedicine."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cmi.2018.03.011","article-title":"Towards precision medicine in sepsis: A position paper from the European society of clinical microbiology and infectious diseases","volume":"24","author":"Rello","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B93","doi-asserted-by":"publisher","first-page":"9768414","DOI":"10.1155\/2020\/9768414","article-title":"Integrated analysis of the mechanisms of da-chai-hu decoction in type 2 diabetes mellitus by a network pharmacology approach","volume":"2020","author":"Ren","year":"2020","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"eaaz2841","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"s77","DOI":"10.7861\/clinmedicine.15-6-s77","article-title":"An overview of the genetics, mechanisms and management of NAFLD and ALD","volume":"15","author":"Rowell","year":"2015","journal-title":"Clin. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted metabolomics strategies-challenges and emerging directions","volume":"27","author":"Schrimpe-Rutledge","year":"2016","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"B98","doi-asserted-by":"publisher","first-page":"8749564","DOI":"10.1155\/2020\/8749564","article-title":"Nonalcoholic fatty liver disease: Pathogenesis and treatment in traditional Chinese medicine and western medicine","volume":"2020","author":"Shi","year":"2020","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/ptr.6054","article-title":"Turmeric (curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review","volume":"32","author":"Soleimani","year":"2018","journal-title":"Phytother. Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","article-title":"Biological properties and clinical applications of berberine","volume":"14","author":"Song","year":"2020","journal-title":"Front. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"107438","DOI":"10.1016\/j.intimp.2021.107438","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages","volume":"94","author":"Sun","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism."},{"key":"B103","doi-asserted-by":"publisher","first-page":"109721","DOI":"10.1016\/j.biopha.2019.109721","article-title":"Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model","volume":"123","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B104","doi-asserted-by":"publisher","first-page":"E649","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"key":"B105","doi-asserted-by":"publisher","first-page":"106002","DOI":"10.1016\/j.phrs.2021.106002","article-title":"Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases","volume":"175","author":"Wan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/1753-0407.13120","article-title":"Integrative analysis of hepatic metabolomic and transcriptomic data reveals potential mechanism of nonalcoholic steatohepatitis in high-fat diet-fed mice","volume":"13","author":"Wang","year":"2020","journal-title":"J. Diabetes"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/ptr.7478","article-title":"Hyperoside: A review on its sources, biological activities, and molecular mechanisms","volume":"36","author":"Wang","year":"2022","journal-title":"Phytother. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"CD004196","DOI":"10.1002\/14651858.CD004196.pub2","article-title":"Puerarin injection for unstable angina pectoris","volume":"3","author":"Wang","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J. Adv. Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4093\/dmj.2019.0042","article-title":"Combination of probiotics and Salvia miltiorrhiza polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice","volume":"44","author":"Wang","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"B111","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/bph.14095","article-title":"Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3969\/j.issn.1008-0805.2020.12.018","article-title":"Study on the effect of yinchenhao decoction on non-alcoholic fatty liver model rats based on serum metabonomics","volume":"31","author":"Wang","year":"","journal-title":"Lishizhen Med. Materia Medica Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"8495953","DOI":"10.1155\/2016\/8495953","article-title":"Untargeted metabolomics reveals intervention effects of total turmeric extract in a rat model of nonalcoholic fatty liver disease","volume":"2016","author":"Wang","year":"2016","journal-title":"Evid. Based. Complement. Altern. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/s12276-020-00534-2","article-title":"Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats","volume":"52","author":"Wang","year":"","journal-title":"Exp. Mol. Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/13543784.2020.1668375","article-title":"Elafibranor: A potential drug for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Westerouen Van Meeteren","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B116","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.clinthera.2021.01.007","article-title":"Nonalcoholic fatty liver disease: A global perspective","volume":"43","author":"Wong","year":"2021","journal-title":"Clin. Ther."},{"key":"B117","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0254-6272(17)30076-6","article-title":"Colon hydrotherapy plus traditional Chinese medicine to treat non-alcoholic fatty liver disease: A pilot study","volume":"37","author":"Xiao","year":"2017","journal-title":"J. Traditional Chin. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: Analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J. Hepatol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1007\/s11033-020-05816-6","article-title":"Anti-inflammatory activities of puerarin in high-fat diet-fed rats with streptozotocin-induced gestational diabetes mellitus","volume":"47","author":"Xu","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B121","doi-asserted-by":"publisher","first-page":"114620","DOI":"10.1016\/j.jpba.2022.114620","article-title":"Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS","volume":"211","author":"Yan","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B122","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.tibs.2016.08.010","article-title":"Lipidomics: Techniques, applications, and outcomes related to biomedical sciences","volume":"41","author":"Yang","year":"2016","journal-title":"Trends biochem. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"112556","DOI":"10.1016\/j.jep.2020.112556","article-title":"Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response","volume":"255","author":"Yang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.3748\/wjg.v24.i23.2468","article-title":"Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis","volume":"24","author":"Ye","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"172715","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-800177-6.00001-3","article-title":"Lipidomics applications for discovering biomarkers of diseases in clinical chemistry","volume":"313","author":"Zhao","year":"2014","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.3748\/wjg.v21.i18.5695","article-title":"Prevalence of fatty liver disease and the economy in China: A systematic review","volume":"21","author":"Zhu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12906-019-2577-6","article-title":"Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA\/circRNA immune ceRNA networks","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijbiomac.2019.01.141","article-title":"Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease","volume":"128","author":"Zhu, H.","year":"2019","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.971561\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T10:51:18Z","timestamp":1661424678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.971561\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":135,"alternative-id":["10.3389\/fphar.2022.971561"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.971561","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"971561"}}